SNDX
Syndax Pharmaceuticals IncCompany with tickers: SNDX
CIK
1395937
CUSIP
87164F105
Shares Outstanding
88,610,027
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $64,864,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $99,066,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Research & Development | $58,845,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Operating Income | $-34,202,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Net Income | $-42,673,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| EPS (Basic) | $-0.48 | USD/shares | 2026-03-31 | 10-Q | 2026-04-30 |
| EPS (Diluted) | $-0.48 | USD/shares | 2026-03-31 | 10-Q | 2026-04-30 |